These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8173071)

  • 1. Clinical management of women at increased risk for breast cancer.
    Vogel VG; Yeomans A; Higginbotham E
    Breast Cancer Res Treat; 1993 Nov; 28(2):195-210. PubMed ID: 8173071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advising women at high risk of breast cancer.
    Wood WC
    Oncology (Williston Park); 2004 Jan; 18(1):28-32; discussion 32-4, 39, 42. PubMed ID: 14768405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention or mastectomy for women at high risk of developing breast cancer.
    Sismondi P; D'Alonzo M; Pecchio S; Bounous VE; Robba E; Biglia N
    Maturitas; 2015 Nov; 82(3):271-3. PubMed ID: 26276104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy.
    Metcalfe KA; Narod SA
    J Natl Cancer Inst; 2002 Oct; 94(20):1564-9. PubMed ID: 12381709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The woman at increased risk for breast cancer: evaluation and management strategies.
    Bilimoria MM; Morrow M
    CA Cancer J Clin; 1995; 45(5):263-78. PubMed ID: 7656130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
    Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic mastectomy: indications, options, and reconstructive alternatives.
    Spear SL; Carter ME; Schwarz K
    Plast Reconstr Surg; 2005 Mar; 115(3):891-909. PubMed ID: 15731693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
    Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC; Schaid DJ; Woods JE; Crotty TP; Myers JL; Arnold PG; Petty PM; Sellers TA; Johnson JL; McDonnell SK; Frost MH; Jenkins RB
    N Engl J Med; 1999 Jan; 340(2):77-84. PubMed ID: 9887158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for managing breast cancer risk after the menopause.
    Warren R; Harvie M; Howell A
    Treat Endocrinol; 2004; 3(5):289-307. PubMed ID: 15330677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine N; Wallace J; Ezzo J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of women at high risk for the development of breast cancer: risk estimation and preventative strategies.
    Sakorafas GH
    Cancer Treat Rev; 2003 Apr; 29(2):79-89. PubMed ID: 12670450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age.
    Black WC; Nease RF; Tosteson AN
    J Natl Cancer Inst; 1995 May; 87(10):720-31. PubMed ID: 7563149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.
    Hermel DJ; Wood ME; Chun J; Rounds T; Sands M; Schwartz S; Schnabel FR
    Clin Breast Cancer; 2017 Oct; 17(6):427-432. PubMed ID: 28539235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
    Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
    Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of prophylactic mastectomy.
    Ghosh K; Hartmann LC
    Oncology (Williston Park); 2002 Oct; 16(10):1319-25; discussion 1325, 1329-30, 1332. PubMed ID: 12435203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.